Vergleich

Recombinant Cynomolgus B7-1/CD80 Protein (Fc Tag)

ArtNr ELS-PKSQ050018-50ug
Hersteller Elabscience
Menge 50ug
Kategorie
Typ Proteins
Specific against other
Host Human Cells
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias T-lymphocyte activation antigen CD80, Activation B7-1 antigen, B7, CD80
Similar products CD80, T-lymphocyte activation antigen CD80, Activation B7-1 antigen, B7, B7
Lieferbar
Synonym
T-lymphocyte activation antigen CD80, Activation B7-1 antigen, B7, CD80
Storage
according to manual
Protein Construction
Recombinant Cynomolgus CD80 is produced by our Mammalian expression system and the target gene encoding Val35-Asn242 is expressed with a Fc tag at the C-terminus.
Sequence
Val35-Asn242
Fusion tag
C-Fc
Accession
G7NXN7
Shipping
This product is provided as lyophilized powder which is shipped with ice packs.
Purity
> 95% as determined by reducing SDS-PAGE.
Endotoxin
< 1.0 EU per ug as determined by the LAL method.
Stability and Storage
Lyophilized proteins are stable for up to 12 months when stored at -20 to -80CC. Reconstituted protein solution can be stored at 4-8C for 2-7 days. Aliquots of reconstituted samples are stable at < -20C for 3 months.
Mol Mass
51 kDa
AP Mol Mass
70-90 kDa
Formulation
Lyophilized from a 0.2 um filtered solution of 50 mM Tris, 100 mM Glycine, pH 7.5.
Reconstitution
Please refer to the printed manual for detailed information.
Background
Cynomologous Cluster of Differentiation 80, also called B7-1, is a member of cell surface immunoglobulin superfamily.It is expressed on the surface of antigen-presenting cells including activated B cells, macrophages and dendritic cells.CD80 plays key, yet distinct roles in the activation of T cells. B7-1/CD80 and B7-2/CD86, together with their receptors CD28 and CTLA4, constitute one of the dominant co-stimulatory pathways that regulate T- and B- cell responses. CD80 is mostly expressed on the surface of antigen-presenting cells including activated B cells, macrophages and dendritic cells. Although both CTLA-4 and CD28 can bind to the same ligands, CTLA-4 binds to B7-1 and B7-2 with a 20-100 fold higher affinity than CD28 and is involved in the down-regulation of the immune response. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 50ug
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen